JP2023090702A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023090702A5 JP2023090702A5 JP2023020473A JP2023020473A JP2023090702A5 JP 2023090702 A5 JP2023090702 A5 JP 2023090702A5 JP 2023020473 A JP2023020473 A JP 2023020473A JP 2023020473 A JP2023020473 A JP 2023020473A JP 2023090702 A5 JP2023090702 A5 JP 2023090702A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- poultry
- variants
- immunogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004196 processed proteins & peptides Human genes 0.000 claims 52
- 108090000765 processed proteins & peptides Proteins 0.000 claims 52
- 229920001184 polypeptide Polymers 0.000 claims 48
- 230000002163 immunogen Effects 0.000 claims 17
- 244000144977 poultry Species 0.000 claims 15
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- 239000002157 polynucleotide Substances 0.000 claims 8
- 102000040430 polynucleotide Human genes 0.000 claims 8
- 108091033319 polynucleotide Proteins 0.000 claims 8
- 229960005486 vaccine Drugs 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 241000193468 Clostridium perfringens Species 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 206010061043 Clostridial infection Diseases 0.000 claims 5
- 208000037384 Clostridium Infections Diseases 0.000 claims 5
- 208000004232 Enteritis Diseases 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 206010017711 Gangrene Diseases 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 230000001338 necrotic effect Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762513001P | 2017-05-31 | 2017-05-31 | |
| US62/513,001 | 2017-05-31 | ||
| JP2020517243A JP2020527051A (ja) | 2017-05-31 | 2018-05-31 | 家禽における壊疽性腸炎に対するワクチン |
| PCT/CA2018/050643 WO2018218360A1 (en) | 2017-05-31 | 2018-05-31 | Vaccine against necrotic enteritis in poultry |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020517243A Division JP2020527051A (ja) | 2017-05-31 | 2018-05-31 | 家禽における壊疽性腸炎に対するワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023090702A JP2023090702A (ja) | 2023-06-29 |
| JP2023090702A5 true JP2023090702A5 (enExample) | 2023-08-25 |
Family
ID=64454163
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020517243A Pending JP2020527051A (ja) | 2017-05-31 | 2018-05-31 | 家禽における壊疽性腸炎に対するワクチン |
| JP2023020473A Pending JP2023090702A (ja) | 2017-05-31 | 2023-02-14 | 家禽における壊疽性腸炎に対するワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020517243A Pending JP2020527051A (ja) | 2017-05-31 | 2018-05-31 | 家禽における壊疽性腸炎に対するワクチン |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11318194B2 (enExample) |
| EP (1) | EP3630800A4 (enExample) |
| JP (2) | JP2020527051A (enExample) |
| CN (1) | CN110691787A (enExample) |
| BR (1) | BR112019025019A2 (enExample) |
| CA (1) | CA3064461A1 (enExample) |
| MX (1) | MX2019014450A (enExample) |
| WO (1) | WO2018218360A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113234130A (zh) * | 2021-05-24 | 2021-08-10 | 安徽医科大学第四附属医院 | 一种卡氏肺孢子菌重组蛋白及其制备方法与应用 |
| WO2025199604A1 (en) * | 2024-03-27 | 2025-10-02 | Université de Montréal | Recombinant vaccine proteins for the prevention of avian necrotic enteritis |
| CN121759384B (zh) * | 2026-03-05 | 2026-06-19 | 吉林农业大学 | 一种靶向树突状细胞的表达产气荚膜梭菌多抗原的重组乳杆菌及其构建方法与应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3614866B2 (ja) * | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ，インコーポレイティド | 人工抗体ポリペプチド |
| HK1045713A1 (zh) * | 1999-07-13 | 2002-12-06 | Medimmune, Inc. | 供体链补体的菌毛蛋白和粘附素宽基疫苗 |
| MY149604A (en) * | 2005-04-18 | 2013-09-13 | Schering Plough Ltd | C.perfringens alpha toxoid vaccine |
| WO2007116322A2 (en) * | 2006-02-17 | 2007-10-18 | Novartis Ag | Purification of bacterial antigens |
| US7745175B2 (en) * | 2006-10-27 | 2010-06-29 | Dow Agrosciences Llc | Polynucleotides encoding Clostridium perfringens alpha toxin proteins |
| EP2086578B1 (en) * | 2006-11-20 | 2012-01-11 | Intervet International B.V. | Use of clostridium perfringens type c bacterium for the manufacture of a vaccine |
| WO2008146164A2 (en) * | 2007-05-25 | 2008-12-04 | Novartis Ag | Streptococcus pneumoniae pilus antigens |
| MX2009012924A (es) * | 2007-06-08 | 2010-03-25 | Australian Poultry Crc Pty Ltd | Toxina clostridial netb. |
| US8501190B2 (en) * | 2007-06-22 | 2013-08-06 | The University Of Guelph | Vaccine against Clostridium perfringens |
| WO2011113801A1 (en) * | 2010-03-16 | 2011-09-22 | Universiteit Gent | Use of clostridium perfringens strain 23 to protect against necrotic enteritis |
| AR099470A1 (es) * | 2014-02-17 | 2016-07-27 | Intervet Int Bv | Vacunas de virus de aves de corral líquidas |
| FR3065623B1 (fr) * | 2017-04-28 | 2021-07-09 | Roquette Freres | Albumines de pois ameliorees, procede d'obtention et leurs applications |
| BR112021000100A2 (pt) * | 2018-07-05 | 2021-03-30 | Novobind Livestock Therapeutics Inc. | Anticorpos contra agentes causadores de doença de aves domésticas e usos dos mesmos |
-
2018
- 2018-05-31 MX MX2019014450A patent/MX2019014450A/es unknown
- 2018-05-31 EP EP18809397.5A patent/EP3630800A4/en not_active Withdrawn
- 2018-05-31 BR BR112019025019-0A patent/BR112019025019A2/pt not_active Application Discontinuation
- 2018-05-31 WO PCT/CA2018/050643 patent/WO2018218360A1/en not_active Ceased
- 2018-05-31 CA CA3064461A patent/CA3064461A1/en active Pending
- 2018-05-31 US US16/616,619 patent/US11318194B2/en not_active Expired - Fee Related
- 2018-05-31 CN CN201880036012.6A patent/CN110691787A/zh active Pending
- 2018-05-31 JP JP2020517243A patent/JP2020527051A/ja active Pending
-
2022
- 2022-03-28 US US17/705,913 patent/US20220226455A1/en not_active Abandoned
-
2023
- 2023-02-14 JP JP2023020473A patent/JP2023090702A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| JP2005511076A5 (enExample) | ||
| JP2013507907A5 (enExample) | ||
| JP2016539946A5 (enExample) | ||
| JP2011250797A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2010162023A5 (enExample) | ||
| JPWO2019107530A5 (enExample) | ||
| JP2023100654A5 (enExample) | ||
| JP2014527526A5 (enExample) | ||
| RU2018122755A (ru) | Слитые белки fmdv-e2 и их применение | |
| RU2019130941A (ru) | РЕКОМБИНАНТНАЯ BCG, СВЕРХЭКСПРЕССИРУЮЩАЯ PhoP-PhoR | |
| JP2023522154A5 (enExample) | ||
| JP2024540358A5 (enExample) | ||
| JP2020527167A5 (enExample) | ||
| KR102675881B1 (ko) | Pedv 스파이크 단백질 s1 유래 단백질 및 페리틴 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| US10596250B2 (en) | Methods of treating and preventing influenza infections | |
| CN117098551A (zh) | 编码截短的ns1蛋白和sars-cov受体结合域的流感病毒 | |
| ES2551699T3 (es) | Composiciones, procedimientos y kits | |
| EA201501001A1 (ru) | Вакцина для профилактики и лечения ротавирусной инфекции, содержащая гибридный белок в качестве активного агента (варианты) | |
| CN107974458A (zh) | 表达猪丹毒杆菌重组蛋白GAPDH的基因gapdh及其重组大肠杆菌与应用 | |
| CN116888139A (zh) | 诱导高水平i型干扰素的新型复制缺陷型甲型流感病毒 | |
| CN111172177B (zh) | cra4S1基因及其编码的蛋白和应用 | |
| JP2023534987A5 (enExample) | ||
| JP2021524485A5 (enExample) |